Growing evidence links pentosan polysulfate sodium, maculopathy
There is growing evidence that pentosan polysulfate sodium (PPS) is associated with an increased risk for maculopathy, according to a study published online Nov. 18 in JAMA Ophthalmology. Gerald McGwin
Read More